Indlela iLamictal ibhalwe ngayo nge-Bipolar Disorder
Zininzi iintlobo ezahlukeneyo kunye neenthamo zeLamictal (lamotrigine) kunokudideka ukuba unqunywe le nyilisi. Ngelixa ugqirha wakho uza kululela imithi yakho kwaye akufundise ekusebenziseni okufanelekileyo, kunokukunceda ukufunda malunga neengcebiso zomenzi kwi-dosing.
I-Lamictal (iLamotrigine) ye-Bipolar Disorder
I-Lamictal (lamotrigine) isetyenziswe njengesigxina se- humod for people with bipolar disorder .
Nangona i-anticonbulsant isetyenziselwa ukunyanga ukuphazamiseka kwengxaki yokugonywa njenge-epilisi, eli nqaku liquka kuphela i-dosages ekhuthazwayo xa kuthathwa i-bipolar disorder.
Kule nqaku siza kuthetha malunga nento ofuna ukuyifumana ukuqinisekisa ukuba ufumene umthamo ofanelekileyo weyeza. Ungathanda kwakhona ukuphonononga ngolwazi olusisiseko malunga neLamictal ye-bipolar disorder , ezinye zeempembelelo eziqhelekileyo zesiqhamo, kunye nenkcazo ye- Lamictal yokuqhawula isilumkiso .
Iifom zeLamictal
I-brand Lamictal iza ngeendlela ezine:
- Lamictal
- I-Lamictal ODT (amaphilisi okutshatyalaliswa ngomlomo)
- I-CD yeLamictal (ifumaneka / ingabonakaliyo)
- I-Lamictal XR, (ukukhululwa okwandisiweyo) - uLamictal XR ayisetyenziselwa ukukhubazeka kwe-bipolar ngoko ayihlanganisiwe kweli nqaku
Amandla anamandla weLamictal (iLamotrigine)
ULamictal ufika kumandla alandelayo. Kufuneka usebenze nogqirha wakho ukuba ufumane ukuba yeyiphi into efanelekileyo yokulinganisa.
- Amacwecwe aseLamictal: 25, 100, 150 kunye no-200 mg
- Amacwecwe ase-Lamictal ODT: 25, 50, 100 kunye no-200 mg
- Iipilisi ze-CD zakwaLamictal: 2, 5 no-25 mg
Indlela yokuthatha i-Lamictal
Xa uthatha uLamictal, kubalulekile ukulandela nayiphi na imiyalelo ugqirha wakho akunike yona. Ngokuqhelekileyo, ukuthatha uLamictal kunje:
- Amacwecwe aseLamictal - Thatha njengawo nawuphi na amanye amayeza kwifomu yepilisi.
- I-Lamictal ODT - Amacwecwe adibeneyo ngokwasemthethweni kufuneka afakwe kulwimi aze ajikeleze emlonyeni. Ithebhulethi iya kutshabalalisa ngokukhawuleza, inokuginywa kunye okanye ngaphandle kwamanzi, kwaye ingathathwa kunye okanye ngaphandle kokutya.
- I-CD yeLamictal - Iiblubhethi zingagxinwa ngokupheleleyo, zichongiwe, okanye zichithwe ngamanzi okanye ijusi yezithelo ezihlanjululwayo. Ukuba iipilisi zihlafunwa, zidle ixabiso elincinci lamanzi okanye ijusi yesithelo esityhulwayo ukuze incedise ukugwinya. Ukusabalalisa iLamictal iifomethe eziphathekayo ezingabonakaliyo, faka iipilisi kwisixa esincinci samanzi (esinye isipuni, okanye okwaneleyo ukugubungela amayeza). Phantse i-ONEC ngomzuzu kamva, xa iipilisi zichithwa ngokupheleleyo, zikhupha isisombululo kwaye zichithe ubuninzi bonke ngokukhawuleza. Akukho mvavanyo ekufuneka yenziwe ukulawula ubuninzi beephilisi ezithekileyo .
I-Manufacturer's Recommended Lamictal Dosages
Iikhitshi zokuqala zifumaneka kumenzi weLamictal kunye neLamictal ODT, kwaye ugqirha wakho unokunikezela enye, kunye nemiyalelo yexesha lokuqalisa ukwandisa ukuya kwinqanaba elilinganayo lezilingo. Imilinganiselo ephakanyisiweyo iyahluka ngoxhomekeke ekubeni uthatha okanye ungathathi ezinye iziyobisi. Ezi zonyango, ezidweliswe ngamagama empawu ze-US kubazali, zi:
- I-valproate ye-sodium okanye i-valproic acid (i-Depakote, i-Depakene, nabanye)
- Carbamazepine (Tegretol)
- Phenytoin (Dilantin)
- IPhenobarbital (Luminol)
- Primidone (Mysoline)
Qaphela: I-Phenytoin, phenobarbital, kunye ne-primidone izidakamizwa ezichasayo ezingasetyenziswanga ukuphazamiseka kwengxaki ye-bipolar.
Njengoko ithebula ibonisa, kubalulekile ukuxelela ugqirha wakho malunga nazo zonke ezinye iziyeza ozithathayo xa uqala unyango lwe-Lamictal kwaye ugcine ugqirha wakho waziswe ngolunye utshintsho kwezinye iyeza.
Uluhlu lweLamictal Isilinganisi
Izigulane UKUQALA Valproate | Izigulane EZINGAKHIWO I-Carbamazepine, iPhenytoin, iPhenobarbital, Primidone, okanye iValproate | Ukufumana izigulane UKWENZA iCarbamazepine, i-Phenytoin, iPhenobarbital, okanye i-Primidone kwaye AKUKHUMBI Valproate | |
| Iiveki 1 no-2 | 25 mg ngalunye usuku | 25 mg ngosuku | 50 mg ngosuku |
| Iiveki 3 no-4 | 25 mg ngosuku | 50 mg ngosuku | 100 mg imihla ngemihla, kwizantlawulo ezihlukeneyo |
| Iveki 5 | 50 mg ngosuku | 100 mg ngosuku | 200 mg imihla ngemihla, ngokwemilinganiselo ehlukeneyo |
| Iveki 6 | 100 mg ngosuku | 200 mg imihla ngemihla | 300 mg imihla ngemihla, ngokwemilinganiselo ehlukeneyo |
| Iveki 7 | 100 mg ngosuku | 200 mg imihla ngemihla | ukuya kwi-400 mg imihla ngemihla, kwimiqathango ehlukeneyo |
| Qaphela: Umvelisi uncoma ukwandisa uLamictal ukuba unqande ukuthabatha uValproate, kwaye ukwandisa ukuba uyeka ukuthatha i-carbamazepine, i-phenytoin, i-phenobarbital okanye i-primidone. Njalo ulandele imiyalelo yesigqirha sakho malunga needayiti - musa ukwenza utshintsho ngokwakho. | |||
| Qaphela: I- contraceptive yomlomo equkethe i-estrogen inokuchaphazela ukusebenza kweLamictal kwaye idinga ukulungiswa kwemilinganiselo. Njalo xelela ugqirha wakho ukuba uthatha, qalisa ukuthatha, okanye uyeke ukuthatha i-oral contraceptive ene-estrogen. | |||
I-Lamictal Dosing in pregnancy
Kulabo abakhulelweyo, banokukhulelwa, okanye basondele ekuhambiseni, unonophelo oluthile kufuneka lithathwe kwi-dosing yeLamictal. Izifundo ziye zafumanisa ukuba i-serum kwi-dose ratio isoloko iyancipha ngexesha lokukhulelwa (ngamanye amagama, i-dose ephakamileyo ingafuneka ukuba ufumane impembelelo efanayo.) Ukuzikhethela kungatshintshwa kanye emva kokuba umntwana ekhutshwa. Olunye uphando lufumanise ukuba amanqanaba eplasma yeziyobisi ayehla ukusuka ekunciphiseni iipesenti ezingama-30 ukunyusa ama-640 ekhulwini emva kokuziswa. Inguqu enkulu kakhulu yenzeke malunga neveki emva kokunikezelwa.
> Imithombo
- > Clark, C., Klein, A., Perel, J., Helsel, J., noK. Wisner. I-Lamotrigine Dosing for Patients Patients with Bipolar Disorder. I-American Journal ye-Psychiatry . 2013. 170 (11): 1240-7.
- > UGlaxo Smith Kline GSKSource. Lamictal. https://www.gsksource.com/lamictal
- > Schoretsanitis, G., Haen, E., Grunder, G. et al. I-Pharmacokinetic I-Drug-drug Interactions ye-Mood Stabilizers kunye ne-Risperidone kwizigulane ngaphantsi kweZonyango eziManyeneyo. Journal of Clinical Psychopharmacology . 2016. 36 (6): 554-561.